The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

said it plans to work with the Trump administration and Congress to fix what it sees as flaws in Medicare's drug price ...

said it plans to work with the Trump administration and Congress to fix what it sees as flaws in Medicare's drug price negotiations. Drug companies also have filed several lawsuits seeking to halt ...

The Centers for Medicare and Medicaid Services is moving forward with Medicare drug price negotiations under the Trump administration, although it said it is seeking to bring "greater transparency ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Why would Trump be OK with forcing Americans to pay more than the rest of the world for their drugs? The answer is simple: ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...